Blaine Davis
Chief Financial Officer
Replay available
Selecta Biosciences, Inc. (SELB) Q2 2023 Earnings Call
Selecta Biosciences, Inc. (NASDAQ: SELB) Q2 2023 earnings conference call, held 2023-08-17. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Kirsten Brunn
President and Chief Executive Officer
Joseph Schertz
Analyst at Lering Partners
Kristin Koleska
Analyst at Cancer Fitzgerald
John Newman
Analyst at Canaccord
Gil Bloom
Analyst at Needham & Company
Ubalan Pachaipan
Analyst at HC Wainwright
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Cartesian Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.029 -- 00:00:06.033 Good morning, everyone, and thank you for joining the Selecta Biosciences Q2 2023 00:00:06.033 -- 00:00:08.234 earnings call. 00:00:08.234 -- 00:00:11.737 At this time, all participants are in a listen-only mode. 00:00:11.737 -- 00:00:16.940 Following management's remarks, we will hold a question and answer session. 00:00:16.940 -- 00:00:22.264 At that time, lines will be open for you. If anyone should require operator assistance, 00:00:22.264 -- 00:00:27.386 please press star and zero on your touch-tone telephones. 00:00:28.328 -- 00:00:33.290 At this time, I'd like to turn the floor over to Blaine Davis, Chief Financial Officer 00:00:33.290 -- 00:00:34.150 at Selecta. Please go ahead. 00:00:34.150 -- 00:00:36.350 Blaine Davis 00:00:37.331 -- 00:00:41.811 Good morning, everyone, and thank you for joining our second quarter 2023 00:00:41.811 -- 00:00:45.652 financial results and business update conference call. 00:00:45.652 -- 00:00:49.693 The press release reporting our financial results is available in the investors and media 00:00:49.693 -- 00:00:54.574 section of Selecta's website at www.selectabio.com. 00:00:55.990 -- 00:01:01.082 and in our quarterly report on Form 10-Q for the quarter ended June 30, 2023, 00:01:01.994 -- 00:01:06.838 which was filed earlier this morning with the Securities and Exchange Commission. 00:01:06.838 -- 00:01:11.061 Joining me on today's call are selected President and Chief Executive Officer Dr. 00:01:11.061 -- 00:01:16.543 Kirsten Brunn and Peter Traver, our Chief Medical Officer. 00:01:16.584 -- 00:01:21.248 During today's call, we will be making certain forward-looking statements, including, 00:01:21.248 -- 00:01:25.997 without limitation, statements about the potential safety, efficacy, and re...